Skip to Content

G 585 (Aprepitant 125 mg)

Pill with imprint G 585 is Pink & White, Capsule-shape and has been identified as Aprepitant 125 mg. It is supplied by Glenmark Pharmaceuticals Inc., USA.

Aprepitant is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Aprepitant 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 585

Aprepitant 125 mg G 585

Aprepitant

Imprint
G 585
Strength
125 mg
Color
Pink & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
NK1 receptor antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc., USA
Manufacturer
Glenmark Pharmaceuticals Limited
National Drug Code (NDC)
68462-0585
Inactive Ingredients
hydroxyethyl cellulose (140 mpa.s at 5%), tocophersolan, poloxamer 407, mannitol, water, sodium stearyl fumarate, microcrystalline cellulose, silicon dioxide, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 3, shellac, ferrosoferric oxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "G 585"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.